CCAL
MRNA icon

City Center Advisors LLC’s Moderna MRNA Stock Holding History

City Center Advisors LLC’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$342K Buy
+1,774
New +$191K 0.26% 115

Other funds holding MRNA

Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
BVL
Beau Ventures, LLc Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
LAI
Legal Advantage Investments Los Altos Hills, California $468M AUM 7.83% 1-Year Est. Return
PFM
Patton Fund Management Dallas, Texas $389M AUM 65.14% 1-Year Est. Return
GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
GCA
Gallagher Capital Advisors Argyle, Texas $187M AUM 21.63% 1-Year Est. Return
NIM
Nicollet Investment Management Minneapolis, Minnesota $336M AUM 22.24% 1-Year Est. Return
BSCCG
Blue Sky Capital Consultants Group Poway, California $239M AUM 14.34% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

City Center Advisors LLC's MRNA Position: Q3 2026 in Review

City Center Advisors LLC opened a new position in Moderna (MRNA) in Q3 2026: 1,774 shares worth $342K. The stake represents 0.26% of the portfolio and ranks #115 among its holdings.

69 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • City Center Advisors LLC held 1,774 shares of Moderna worth $342K as of Q3 2026.
  • Moderna was a new City Center Advisors LLC position in Q3 2026.
  • Moderna made up 0.26% of City Center Advisors LLC's portfolio in Q3 2026, its #115 holding.
  • 69 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on City Center Advisors LLC's 13F filing for Q3 2026, filed 8 Oct 2026.